Effects of electroacupuncture combined with paliperidone palmitate long-acting injection on withdrawal symptoms and neurotransmitters in methamphetamine addicts

被引:0
|
作者
Chen, Yu [1 ]
Wei, Wen-Jie [1 ]
Gong, Ji-Fen [1 ]
Qiao, Juan [1 ]
Wu, Chun-Xi [1 ]
Wang, Xiao-Jun [1 ]
Ding, Ying [1 ]
Chen, Hong-Yuan [1 ]
Lu, Hua-Xin [1 ]
Li, Ming-Chao [2 ]
Ji, Qiu-Ming [1 ]
机构
[1] Wuhan Wudong Hosp, Dept Psychiat, 46 Wudong St, Wuhan 430084, Peoples R China
[2] Wuhan Mental Hlth Ctr, Dept Psychiat, Wuhan, Peoples R China
关键词
Electroacupuncture treatment; methamphetamine; neurotransmitters; paliperidone palmitate long-acting injection; CLINICAL-PHARMACOLOGY; SCHIZOPHRENIA; NEUROTOXICITY;
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
. Objective. To investigate the effects of electroacupuncture combined with paliperidone palmitate long-acting injection (PP-LAI) on withdrawal symptoms and neurotransmitters in methamphetamine (MA) addicts. Materials and methods. A total of 109 methamphetamine addicts, who were treated in the hospital from October 2021 to October 2022, were selected. According to the random number table, the patients were divided into the study group (n=54) and the control group (n=55), in which the control group was treated with PP-LAI and the study group was treated with electroacupuncture on the basis of the control group; the methamphetamine withdrawal symptom score scale was used to assess the therapeutic effect before treatment and within 12 months after treatment; the changes of brain neurotransmitters dopamine, gamma-aminobutyric acid, serotonin, acetylcholine values were compared between the two groups. Results .1) There was no statistical difference in MA withdrawal symptom scores between the two groups before treatment (p>0.05); 2) MA withdrawal symptom scores have a statistically significant difference between the study group and the control group after 3 and 6 months of treatment; 3) dopamine levels in the study group were significantly higher than those in the control group after 6 months of completion of treatment, and gamma-aminobutyric acid values and 5- serotonin values in the study group were significantly lower than those in the control group (p<0.05). Conclusions. Electroacupuncture combined with PP-LAI can partially improve the withdrawal symptoms and anxiety of methamphetamine addicts. This is a potential treatment for preventing relapse of withdrawal symptoms.
引用
收藏
页码:120 / 126
页数:7
相关论文
共 50 条
  • [1] Clinical Study of Paliperidone Palmitate Long-Acting Injection Combined With Electroacupuncture in the Treatment of Methamphetamine Addicts
    Chen, Yu
    Li, Mingchao
    Ji, Qiuming
    Su, Zou
    Yang, Ziyu
    Xu, Yin
    Chen, Qian
    Liao, Dan
    Zeng, Jihua
    Yang, Yuhong
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [2] Hospitalizations and economic analysis in psychotic patients with paliperidone palmitate long-acting injection
    Mesones-Peral, Jesus E.
    Gurillo-Munoz, Pedro
    Paz Sanchez-Sicilia, Mari
    Miller, Adam
    Grinant-Fernandez, Alejandra
    REVISTA DE PSIQUIATRIA Y SALUD MENTAL, 2017, 10 (01): : 33 - 37
  • [3] A case report of pregnancy and paliperidone palmitate 3-monthly long-acting injection
    de Azevedo Avelar, Rita
    Luengo Corbal, Antonio
    Heitor, Maria Joao
    CLINICAL CASE REPORTS, 2020, 8 (12): : 2592 - 2594
  • [4] The impact of paliperidone palmitate long-acting injection on hospital admissions in a mental health setting
    Nikolic, Nikola
    Page, Natalie
    Akram, Adil
    Khan, Maha
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2017, 32 (02) : 95 - 102
  • [5] Alternative initiation regimen of paliperidone palmitate long-acting injectable
    Menendez Gil, I. E.
    Romero Guillena, S. L.
    Plasencia Garcia De Diego, B. O.
    EUROPEAN PSYCHIATRY, 2022, 65 : S284 - S285
  • [6] Effectiveness of long-acting paliperidone palmitate in borderline personality disorder
    Palomares, Nerea
    Montes, Ana
    Diaz-Marsa, Marina
    Carrasco, Jose L.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2015, 30 (06) : 338 - 341
  • [7] A randomized trial of paliperidone palmitate and risperidone long-acting injectable in schizophrenia
    Fleischhacker, W. Wolfgang
    Gopal, Srihari
    Lane, Rosanne
    Gassmann-Mayer, Cristiana
    Lim, Pilar
    Hough, David
    Remmerie, Bart
    Eerdekens, Marielle
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 (01): : 107 - 118
  • [8] Onset of Efficacy of Long-acting Injectable Paliperidone Palmitate for Negative Symptoms and Anxiety/Depression in Subjects With Schizophrenia
    Fu, Dong-Jing
    Bossie, Cynthia A.
    Sliwa, Jennifer Kern
    Ma, Yi-Wen
    Alphs, Larry
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S511 - S512
  • [9] Effectiveness of paliperidone long-acting injection in clinical practice
    Deslandes, Paul Nicholas
    Ward, Elan Haf
    Norris, Kathryn
    Sewell, Robert David
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2018, 8 (05) : 139 - 145
  • [10] Angioedema Associated With Long-Acting Injectable Paliperidone Palmitate: A Case Report
    Papadopoulou, Athanasia
    Gkikas, Kitsos
    Efstathiou, Vasiliki
    Gkikas, Ilias
    Kokoris, Styliani
    Lagari, Vasiliki
    Papageorgiou, Charalabos
    Douzenis, Athanasios
    Siafakas, Nikolaos
    Rizos, Emmanouil N.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2017, 37 (06) : 730 - 732